Sign in

CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
270604595
Phone
781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-31 Iwicki Mark T CHIEF EXECUTIVE OFFICER Returned to the company · Stock Option (right to buy) −6,059 0
2023-05-31 Iwicki Mark T CHIEF EXECUTIVE OFFICER Returned to the company · Stock Option (right to buy) −15,499 0
2023-05-31 Iwicki Mark T CHIEF EXECUTIVE OFFICER Returned to the company · Stock Option (right to buy) −2,268 0
2023-03-14 Kharabi Darius CHIEF BUSINESS OFFICER Grant or award · Stock Option (Right to Buy) +432 432
2023-03-14 Trachtenberg Eric SEE REMARKS Grant or award · Stock Option (Right to Buy) +432 432
2023-03-14 Reumuth Mary CHIEF FINANCIAL OFFICER Grant or award · Stock Option (Right to Buy) +432 432
2023-03-14 Brazzell Romulus K SEE REMARKS Grant or award · Stock Option (Right to Buy) +576 576
2023-03-14 Bazemore Todd SEE REMARKS Grant or award · Stock Option (Right to Buy) +576 576
2023-03-14 Iwicki Mark T CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (Right to Buy) +1,512 1,512
2023-03-10 Blumenkranz Mark S. Director Grant or award +2,013 5,167
2023-03-10 Blumenkranz Mark S. Director Grant or award +65,634 168,454
2023-03-10 Blumenkranz Mark S. Director Grant or award +497 1,276
2023-03-10 Kharabi Darius CHIEF BUSINESS OFFICER Grant or award +6,977 22,407
2023-02-15 Blumenkranz Mark S. Director Other disposition −3 3,154
2023-02-15 Blumenkranz Mark S. Director Other disposition −68 102,820
2023-02-15 Blumenkranz Mark S. Director Other disposition −2 779
2023-01-04 Kharabi Darius CHIEF BUSINESS OFFICER Grant or award +9,525 15,439
2023-01-04 Trachtenberg Eric SEE REMARKS Grant or award +9,525 11,555
2023-01-04 Trachtenberg Eric SEE REMARKS Sale −60 $28.55 $2K 11,495
2023-01-04 Reumuth Mary CHIEF FINANCIAL OFFICER Grant or award +9,525 11,943

Page 11 of 12 · 236 trades